These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7902885)

  • 1. [Immunohistochemical study of c-erbB-2 proto-oncogene product in prostatic cancer].
    Kokuho M; Yoshiki T; Hamaguchi A; Okada Y; Tomoyoshi T; Higuchi K
    Nihon Hinyokika Gakkai Zasshi; 1993 Oct; 84(10):1872-8. PubMed ID: 7902885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma.
    Kuhn EJ; Kurnot RA; Sesterhenn IA; Chang EH; Moul JW
    J Urol; 1993 Nov; 150(5 Pt 1):1427-33. PubMed ID: 8105108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations.
    Fléjou JF; Paraf F; Muzeau F; Fékété F; Hénin D; Jothy S; Potet F
    J Clin Pathol; 1994 Jan; 47(1):23-6. PubMed ID: 7907608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of c-erbB-2 and epidermal growth factor receptor in stage A1 (T1a) prostatic adenocarcinoma.
    Fox SB; Persad RA; Coleman N; Day CA; Silcocks PB; Collins CC
    Br J Urol; 1994 Aug; 74(2):214-20. PubMed ID: 7921940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.
    Uchino S; Tsuda H; Maruyama K; Kinoshita T; Sasako M; Saito T; Kobayashi M; Hirohashi S
    Cancer; 1993 Dec; 72(11):3179-84. PubMed ID: 7902202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of proliferating cell nuclear antigen (PC10), p53 protein and c-erbB-2 in renal adenocarcinoma.
    Lipponen P; Eskelinen M; Hietala K; Syrjänen K; Gambetta RA
    Int J Cancer; 1994 Apr; 57(2):275-80. PubMed ID: 7908898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate.
    Mellon K; Thompson S; Charlton RG; Marsh C; Robinson M; Lane DP; Harris AL; Horne CH; Neal DE
    J Urol; 1992 Feb; 147(2):496-9. PubMed ID: 1370701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of NEU/HER-2 oncoprotein (p185neu) in prostate tumors: an immunohistochemical study.
    Giri DK; Wadhwa SN; Upadhaya SN; Talwar GP
    Prostate; 1993; 23(4):329-36. PubMed ID: 7505056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGF-R and overexpression of the oncogene c-erbB-2 in ovarian cancer: immunohistochemical findings and prognostic value.
    Meden H; Marx D; Raab T; Kron M; Schauer A; Kuhn W
    J Obstet Gynaecol (Tokyo 1995); 1995 Apr; 21(2):167-78. PubMed ID: 8556578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix.
    Kihana T; Tsuda H; Teshima S; Nomoto K; Tsugane S; Sonoda T; Matsuura S; Hirohashi S
    Cancer; 1994 Jan; 73(1):148-53. PubMed ID: 7506116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-erbB-2 Oncoprotein expression is associated with poor prognosis in squamous cell carcinoma of the cervix.
    Oka K; Nakano T; Arai T
    Cancer; 1994 Feb; 73(3):664-71. PubMed ID: 7905364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
    Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
    Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-erbB-2 oncoprotein immunostaining in serous effusions.
    Ascoli V; Scalzo CC; Nardi F
    Cytopathology; 1993; 4(4):207-18. PubMed ID: 8104524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.
    Wright C; Nicholson S; Angus B; Sainsbury JR; Farndon J; Cairns J; Harris AL; Horne CH
    Br J Cancer; 1992 Jan; 65(1):118-21. PubMed ID: 1346366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and characterization of a polyclonal antibody to the c-erbB-3 protein: examination of c-erbB-3 protein expression in adenocarcinomas.
    Poller DN; Spendlove I; Baker C; Church R; Ellis IO; Plowman GD; Mayer RJ
    J Pathol; 1992 Nov; 168(3):275-80. PubMed ID: 1361526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of immunohistochemical c-erbB-2 product localization pattern for prognosis of primary human breast cancer.
    Zschiesche W; Schönborn I; Minguillon C; Spitzer E
    Cancer Lett; 1994 Jun; 81(1):89-94. PubMed ID: 7912648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of c-erbB-2 oncogene product and epidermal growth factor receptor expression in human urinary bladder carcinomas.
    Asamoto M; Hasegawa R; Masuko T; Hashimoto Y; Ueda K; Ohtaguro K; Sasaki S; Washida H; Fukushima S
    Acta Pathol Jpn; 1990 May; 40(5):322-6. PubMed ID: 2203226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.
    Travis A; Pinder SE; Robertson JF; Bell JA; Wencyk P; Gullick WJ; Nicholson RI; Poller DN; Blamey RW; Elston CW; Ellis IO
    Br J Cancer; 1996 Jul; 74(2):229-33. PubMed ID: 8688326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection.
    Motojima K; Furui J; Kohara N; Izawa K; Kanematsu T; Shiku H
    Surgery; 1994 Mar; 115(3):349-54. PubMed ID: 7907434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical study.
    Gasparini G; Gullick WJ; Maluta S; Dalla Palma P; Caffo O; Leonardi E; Boracchi P; Pozza F; Lemoine NR; Bevilacqua P
    Eur J Cancer; 1994; 30A(1):16-22. PubMed ID: 7908213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.